Method of complex treatment of adenoid disease

FIELD: medicine.

SUBSTANCE: invention is referred to medicine, namely - to otorhinolaryngology, physiotherapy. 3 ml of 0.5 % solution of dihydroquercetin administer into palatine tonsils lacunas. Then affect a surface of palatine tonsils with a distal end face of a flexible light guide of light-emitting diode apparatus "АФС/С". The wavelength is 0.45 microns; the maximum power output of radiation 120 mW, diameter of light spot from 3 to 5 cm. Duration of treatment takes 5 minutes on each tonsil. The course of treatment takes 5 sessions. The method provides deep penetration and fast absorption of a medicinal preparation with mucosa of palatine tonsils.

EFFECT: provision of deep penetration and a fast absorption of a medicinal preparation with mucosa of palatine tonsils.

1 ex, 2 tbl

 

The invention relates to medicine, namely to physiotherapy treatment of chronic tonsillitis with led phototherapy in otorhinolaryngology.

There is a method local magnetic-laser therapy (MLT) in the treatment of chronic tonsillitis [1].

The method of local magnetic-laser therapy (MLT) is carried out in two models: AMO-ATOS - magnetotherapy traveling magnetic field with the installation of the radiator on sacilotto region and LAST-ENT laser on faringealni technique. The nature of the effect is stable, the exposure time 3-5 min on each amygdala, the rate of 10-12 days.

The disadvantages are the counterpart:

1. The effect of laser therapy is not effective without the simultaneous application of it with antibiotics, sulfonamides, desensibilisation and other means.

2. Laser physiotherapy is carried out at a low intensity radiation, which leads to the later normalization of biochemical parameters of blood in patients with chronic tonsillitis, as a criterion for effective treatment.

As a prototype method taken led phototherapy in the treatment of diseases of the ear, nose, and throat [2]. Carried out led therapy device ASF in the treatment of allergic rhinitis as when using projection methods for affecting the skin Nar is the author of the nose and the area of projection of its sinuses, and endonasal, irradiating the mucous membrane of the nasal cavity and nasopharynx.

The disadvantage of the prototype is that the radiation exposure of the led device ASF different wavelengths without complex application with antibiotics, antiseptics is not effective.

The purpose of this invention is to develop a method for deeper penetration and rapid absorption by the surface of the mucous membrane of the tonsils drug with antioxidant (0.5%aqueous solution of dihydroquercetin), under the influence of the blue spectrum of light while led phototherapy apparatus ASF/With chronic tonsillitis.

This objective is solved by the fact that previously been filling in the gaps of the Palatine tonsils (6-8 gaps) with 0.5%solution of dihydroquercetin in volume of 3 ml with subsequent illumination of the surface of the mucous membrane of the tonsils distal end of the flexible light guide led apparatus ASF/S with a wavelength of 0.45 μm, a maximum output radiation power of 120 mW, the diameter of the light spot when the illumination of the mucous membrane of the tonsils from 3 to 5 cm, the exposure duration 5 minutes per amygdala, the course of treatment was 5 sessions a blue spectrum of light.

Specific example

We observed 10 sick is in age from 23 to 49 years with chronic tonsillitis.

Example. Patient A., aged 30, was in outpatient treatment in the ENT Department of OCB with a diagnosis of chronic tonsillitis, asthma form. After the examination the patient was implemented method of filling in the gaps of the tonsils (6-8 gaps) with 0.5%solution of dihydroquercetin in volume of 3 ml with subsequent illumination of the surface of the mucous membrane of the tonsils distal end of the flexible light guide led apparatus ASF/S with a wavelength of 0.45 μm, a maximum output radiation power of 120 mW, the diameter of the light spot from 3 to 5 cm, the exposure duration 5 minutes per amygdala, the course of treatment was 5 sessions a blue spectrum of light. The procedure is performed in the examination room.

Concurrent with the led phototherapy surface of the Palatine tonsils conducted a study of biochemical parameters of blood to assess the effectiveness of the treatment in comparison with patients who were blood electrophoresis with CaCl2in the submandibular region (table 1).

Dynamics of indicators of lipid peroxidation after treatment (table 1).

Table 1
Indicators in nmol/lIndices before treatment in nmol/l (n=10)Electrophoresis with CaCl2(n5) Intracavitary led therapy (n=5)
The gidroperekisi lipids (norm - 25,0-35,0 nmol/ml)37,9±0,236,9±0,234,7±0,2
Diene conjugates (norm - 25,0-40.0 nmol/ml)51,6±0,349,7±0,343,9±0,2
Malonic dialdehyde (norm - 5,0-6,5 nmol/ml)7,6±0,17,1±0,126,7±0,11

Led phototherapy contributed to the reduction of the inflammatory process in the Palatine tonsil, which was confirmed by the inhibition of the processes of lipid peroxidation and increased antioxidant protection of tissues (table 2).

Dynamics of indicators of antioxidant protection after treatment (table 2).

Table 2
The figures in mg/mlIndices before treatment in mg/mlElectrophoresis with CaCl2Intracavitary led therapy
Tocopherol acetate (norm - 20,0-25,0 mg/ml)19,4±0,1819,7±0,1622,5±0,2
Ceruloplasmin (norm - 20,0-25,0 mg/ml)16,7±0,1217,7±0,1320,1±0,2

Sources of information

1. Deacons AV, raigorodsky, Y.M. Effectiveness of a combination of General magnetotherapy and local magnetic effects in the conservative treatment of chronic tonsillitis // Bulletin of otorhinolaryngology. - 2006. No. 3. - p.19-22.

2. Nasedkin A.N., Grachev SV, Abrahamian ZH.N. et al. Comparison of clinical indicators of the effectiveness of laser therapy and led phototherapy in the treatment of diseases of the ear, nose and throat // Health care and medical equipment. - 2005. No. 8 (22). - p.45.

The method of complex treatment of chronic tonsillitis by exposure led therapy, characterized in that prior to exposure to blue led emission led device ASF/C in the cavity of the lacunae of the tonsils injected 3 ml of 0.5% solution of dihydroquercetin, then the surface of the tonsils affect distal end of the flexible light guide led apparatus ASF/S with a wavelength of 0.45 μm, a maximum output radiation power of 120 mW, the diameter of the light spot from 3 to 5 cm, the exposure duration 5 min on each amygdala, the course of treatment was 5 sessions.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention is referred to medicine, namely - to otorhinolaryngology, physiotherapy. 3 ml of 0.5 % solution of dihydroquercetin administer into palatine tonsils lacunas. Then affect a surface of palatine tonsils with a distal end face of a flexible light guide of light-emitting diode apparatus "АФС/ИК". The wavelength is 0.85 microns; the maximum power output of radiation 60 mW, diameter of light spot from 3 to 5 cm. Duration of treatment takes 5 minutes on each tonsil. The course of treatment takes 5 sessions. The method allows providing deeper and faster absorption of the medicinal preparation with a surface of mucosa of palatine tonsils possessing antioxidatic action, reducing inflammatory process in palatine tonsils, thus to slow down the process of peroxidation of lipids and to raise level of antioxidatic protection of tissues.

EFFECT: provision of deep penetration and fast absorption of a medicinal preparation by mucosa of palatine tonsils.

2 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: invention is referred to medicine, namely - to otorhinolaryngology, physiotherapy. 3 ml of 0.5 % solution of dihydroquercetin administer into palatine tonsils lacunas. Then affect a surface of palatine tonsils with a distal end face of a flexible light guide of light-emitting diode apparatus "АФС/З". The wavelength is 0.53 microns; the maximum power output of radiation 60 mW, diameter of light spot from 3 to 5 cm. Duration of treatment takes 5 minutes on each tonsil. The course of treatment takes 5 sessions. The method provides deep penetration and fast absorption of a medicinal preparation with mucosa of palatine tonsils.

EFFECT: provision of deep penetration and a fast absorption of a medicinal preparation with mucosa of palatine tonsils.

1 ex, 2 tbl

FIELD: medicine; pharmacology.

SUBSTANCE: pharmaceutical formulation as solid dosage form for local treatment of mouth and pharynx inflammatory diseases, containing at least one mucus-producing medicinal plant as dry extract and at least one local analgesic taken in specified ratio. Application of pharmaceutical formulation described above for local treatment of painful inflammatory diseases of mouth cavity and pharynx.

EFFECT: composition is effective for local treatment of painful inflammatory diseases of mouth cavity and pharynx.

9 cl, 4 tbl

FIELD: medicine; otorhinolaryngology.

SUBSTANCE: application anaesthesia of posterior wall pharynx mucous membrane is performed with 10% lydocaine solution, and then 1 ml of 0.001% dalargin aqueous solution is injected in submucosa.

EFFECT: enables to reduce treatment time due to activated regeneration of pharynx mucous membrane and improved intratissual microcirculation.

2 tbl, 2 ex

FIELD: medicine; veterinary.

SUBSTANCE: antagonists of metabotropic glutamate receptor 5 (MGLUR5) are suggested to inhibit the transit relaxation of the inferior esophageal sphincter, as well as the corresponding method of treatment and/or prevention of related disorders. Particularly, such disorders include gastroesophageal reflux, gastroesophageal reflux disease, regurgitation, pulmonary disease, hypoplasia of organism, and asthma. The following antagonists of metabotropic glutamate receptor 5 are preferable: 2-methyl-6-(fenyl-etynyl) pyridine, hydrochloride 2- methyl-6-(fenyl-etynyl) pyridine, 3-[3-(5- fluoropyridine -2-il)-1,2,4-oxadiazol-5-il]-5-(metoxymethyl) benzonitrile, 3-fluor-5-[3-(5- fluoropyridine -2-il)-1,2,4- oxadiazol-5-il] benzonitrile.

EFFECT: compounds inhibited the pressure of inferior esophageal sphincter decreased by infusion pomp, in dogs.

26 cl, 4 tbl, 3 ex

FIELD: medicine, otorhinolaryngology.

SUBSTANCE: invention proposes a composition that prevents dryness in mouth and voice "breaking" and maintains tonus of vocal chords comprising the following components, weight %: (a) Piper cubeba extract, 0.5-2; (b) Glycyrrhiza glabra extract, 0.5-2; (c) Acorus calamus extract, 0.01-0.1; (d) Alpinia galanga extract, 0.01-0.1; (e) Zingiber officinale extract, 0.01-0.1, and (f) pharmaceutically acceptable additives, the balance. Method for preparing the composition involves the following steps: (a) preparing necessary parts of medicinal plants; (b) drying vegetable material from step (a) in shade; (c) milling dried vegetable material from step (b) for preparing small powder; (d) extraction of milled vegetable material from step (c) with aqueous-alcoholic solution at temperature 25-350C for 4-7 days for preparing aqueous-alcoholic extract; (e) concentrating the extract from step (d) under reduced pressure and temperature 40-600C for preparing the concentrated extract; (f) lyophilization of the concentrated extract from step (e) for complete removal of solvent residue and preparing the necessary vegetable extract, and (g) addition of vegetable extract from step (f) to prescription in common with suitable pharmaceutically acceptable additives for preparing the necessary composition. The composition is used in bronchitis and allergic throat diseases. Invention provides realization of indicated designations.

EFFECT: valuable medicinal properties of composition.

35 cl, 2 tbl, 5 ex

FIELD: otolaryngology.

SUBSTANCE: endoscopy-controlled tissue of adenoid vegetation is pretreated with 0.01% miramistin solution, after which 8-10 mL of 0.1% levamisol are introduced into adenoid crypts.

EFFECT: enhanced treatment efficiency due to optimal amounts and concentrations of drugs as well as methods for administration thereof.

2 ex

FIELD: medicine, otorhinolaryngology.

SUBSTANCE: invention relates to a method for treatment of chronic hyperplastic laryngitis. Method involves using the immunoglobulin preparation "Immunovenin" for intravenous administration that is administrated by drop route as a single dose 25.0 ml at the rate 10-20 drops/min. Method provides reducing treatment period, diminishing complications as candidiasis and amounts of relapses based on enhancing formation of antibodies, especially of G class, and retaining high phagocytic activity of neutrophiles.

EFFECT: improved method of treatment.

1 tbl, 1 ex

FIELD: otolaryngology.

SUBSTANCE: in order to treat tonsillitis, ml of 1% solution of emoxipine is introduced into lacunas of palatine tonsils, after which the latter are exposed to helium-neon laser radiation with wavelength 0.63 μm, maximum output power 10-20 mW, light spot diameter 2-3 mm, and power flow density 35-60 W/cm2, distal end of monofiber beamguide being introduced into lacuna cavity. Single dose ranges from 3.0 to 5.5 J/cm. Radiation exposition time is 2 min per 1 lacuna and full course consists of 5-7 procedures.

EFFECT: accelerated accumulation of required concentration of emoxipine in tissues of palatine tonsils so enhancing treatment efficiency.

2 tbl

FIELD: medicine, otorhinolaryngology.

SUBSTANCE: method involves administration in patient 1% emoxipine solution in the volume 1 ml to lateral and posterior sections of mouth-pharynx after its preliminary application anesthesia with 2% lidocaine solution by submucosa injection. The treatment course is 5-10 procedures with break for 1 day. Method provides the stable clinical effect of treatment based on rapid accumulation of the required concentration of the medicinal preparation both in pharynx mucosa and in blood. Invention can be used in treatment of chronic pharyngitis.

EFFECT: improved method of treatment.

2 tbl, 1 ex

FIELD: medicine, oncology.

SUBSTANCE: starting from 5-8 day after operation, daily exposure of all post-operation zone including axillary region to infrared laser irradiation is performed with defocused ray during 0.5-2 minutes, constant magnetic field, intensity of magnetic induction within 20-50 mT, frequency of recurrence rate of impulse laser irradiation of infrared spectrum within 80 Hz, power of 0.5-1.0 W. Course includes 5-8 procedures depending on type of post-operation complication. In 10-30 days after operation, area of shoulder and mammary gland are exposed to magnetic field of sinusoidal form, with intensity of 10-20 mT, during 5 minutes, daily, the course includes 10-12 procedures.

EFFECT: reduction of recurrence rate of side effects and post-operation complications, prevention of keloid cicatrix development and prevention of lymphostasis development.

2 ex

FIELD: medicine, oncology.

SUBSTANCE: method includes local heating of internal tissues of human organism by exposing to laser irradiation. Adjustment of irradiation wavelength is performed so, that depth of penetration into tissues makes 3 to 10 cm, using source of irradiation which generates within the range of λ±0.02λ. Laser irradiation is focused at the distance of 3 to 15 cm under body surface into spot with linear size of 1 mm. Irradiation power is calculated from these parameters. To minimise zone of thermal impact during exposure, measurement of irradiation power in time is carried out. For this, such irradiation system forming laser is used that ensures required distribution of specific volume of energy contribution in region of local heating.

EFFECT: increase in local heating of internal tissues without mechanical contact with heated region and without using methods of irradiation concentration.

5 cl, 8 dwg

FIELD: medicine.

SUBSTANCE: double-sided magnetic exposure on regions of hypothalamus projection on temporal bone and on paravertebral zones at level Th8-Th11 is carried out successively. Then exposure to bipolar electric stimulation between rectum and suprapubic zone and laser irradiation on perineum are performed. Time of magnetic exposure on one zone is 5 minutes. Time of laser exposure is 10 minutes. Time of electric exposure is 30 minutes. Course of treatment lasts for 15 days.

EFFECT: improvement of functional state of central and spinal vegetative centres, increase in exchange processes, ensuring outflow of intracellular fluid into lymphatic vessels and creation of optimal conditions for electric stimulation of gland.

1 ex

FIELD: medicine, ophthalmology.

SUBSTANCE: after mechanical removal of grown-in cells, photosensibilising gel containing 0.05% of chlorine line photosensibiliser, is applied on stromal bed on regions of cell growing-in. It is held for one minute. Then remains of gel are removed and flap is put onto its place. Then transcorneal irradiation of regions of stromal bed in places of cornea epithelium growing-in with laser irradiation by fields, with covering adjacent fields on 5% of area, is performed. Energy density during irradiation is 10-15 Joule/cm².

EFFECT: method ensures destruction of remaining after scarification epithelium cells, adequate adaptation of cornea flap due to improvement of adhesion and absence of relapses or progressing of growing-in of cornea epithelium cells under flap.

1 ex

FIELD: medicine, ophthalmology.

SUBSTANCE: after removal of deep scleral flap, external wall of Schlemm's canal and corneoscleral tissue, photosensibilising gel, which contains 0.5% of chlorine line PS is applied on scleral bed. Superficial scleral flap is placed and held for 1-2 minutes. After that, flap is lifted and remains of gel are removed. Laser irradiation of scleral bed and internal surface of superficial scleral flap by fields with energy density 20 Joule/cm² per one field is performed.

EFFECT: long retention of paths of intraocular liquid outflow, created during anti-glaucoma operation.

2 ex

FIELD: medicine; ophthalmology.

SUBSTANCE: intravenously enter a photosensitinogen of a chlorine number in a dose of 0.5 mg/kg within 10 minutes. Simultaneously with it perform intravenous laser irradiation of blood in cubital vein of other arm. Thus the wavelength corresponds to a maximum of "ФС" absorption of light radiation of 50 mW power. Then transpupillary irradiate the centre with one laser emission maculae with the same wavelength and density of energy 15 J/cm2.

EFFECT: method allows to reach a selective obliteration of neogenic vessels of choroidal neovascular membranes at the minimum damaging influence on intact structures of a retina.

2 ex

FIELD: medicine.

SUBSTANCE: drainage of the infection centre is performed. A spectrum of microorganisms present at it is defined. The microorganisms are ranged, proceeding from their relative quantities. The centre is irradiated with the laser emitting ultra-violet light. Thus a choice of a wavelength of an irradiation is carried out for one or several species of microorganisms taking highest on a rating a place.

EFFECT: increased efficiency of treatment due to choice of wavelength, taking into account ranging of microorganisms.

3 tbl, 1 dwg

FIELD: medicine; urology.

SUBSTANCE: method includes making a diagnosis, allocating originators from the primary and secondary centres of patient's infection, and, after definition , using cultural method, of their sensitivity to the most effective etiotropic preparation, injecting it to a patient. After taking the blood from the patient, separating it into plasma, suspension erythrocytes and phagocytes by means of consecutive rotation with the rate of 2100 rpm for 10 minutes, cooling them preliminary to the temperature of +5°C, the method further includes deleting toxic blood plasma and replacing, in peer quantity, with Ringer solution and, with the suspension of erythrocytes entered into this solution, driply parenterally injecting in a vascular bed of a patient. The suspension of phagocytes, after being irradiated with emission of helium-neon laser of λ=0.63 mcm for 10-15 minutes power to 15 MW, is saturated with a solution of etiotropic ofloxacin preparation in a dose of 400 mg and, being sustained for 30 minutes, the solution obtained is injected parenterally intravenously to a patient. Nifuratel is injected perorally to a patient in a dose of 400 mg. A course comprises 12 procedures daily.

EFFECT: raised efficiency of treatment; reduced terms of treatment and decreased by-effects.

2 ex

FIELD: medicine; ophthalmology.

SUBSTANCE: exposure to infrared laser with wavelength of 810-890 nm and voltage of 6 mW is performed for 1-1.5 minutes daily in 3-4 days. Then exposure to He-Ne laser pulse radiation with wavelength of 0.63 mcm, average energy illuminance of 0.01-1.5 J/cm2 and pulse frequency of 2-5 kHz is performed for 1-1.5 minutes daily in 2-3 days.

EFFECT: proliferation of scar tissues with good morphological and functional result.

2 ex

FIELD: medicine.

SUBSTANCE: device contains a source of laser emission, installed with possibility of laser radiation light dose regulation directed to area of skin neoformation, and appliance for eye defence against laser radiation. At the same time appliance for eye defense against laser radiation is designed in the form of frontal holder. Plate is fastened on the front holder with possibility of fixation in preset position and unite with hingedly supported plate made of medical steel in the form of convex ellipse inverted to eye by its concave surface. Made of medical steel plate is fastened with possibility to place it between source of radiation, and both in front of eye and under upper or lower eyelid.

EFFECT: application of the device allows to improve effectiveness of treatment due to elimination of eye-lesion possibility.

4 dwg, 1 ex

FIELD: medicine.

SUBSTANCE: invention is referred to medicine, namely - to otorhinolaryngology, physiotherapy. 3 ml of 0.5 % solution of dihydroquercetin administer into palatine tonsils lacunas. Then affect a surface of palatine tonsils with a distal end face of a flexible light guide of light-emitting diode apparatus "АФС/З". The wavelength is 0.53 microns; the maximum power output of radiation 60 mW, diameter of light spot from 3 to 5 cm. Duration of treatment takes 5 minutes on each tonsil. The course of treatment takes 5 sessions. The method provides deep penetration and fast absorption of a medicinal preparation with mucosa of palatine tonsils.

EFFECT: provision of deep penetration and a fast absorption of a medicinal preparation with mucosa of palatine tonsils.

1 ex, 2 tbl

Up!